Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium | 74 | 2023 | 369 | 10.730 |
Why?
|
| Muscle, Skeletal | 53 | 2023 | 341 | 8.950 |
Why?
|
| Calcium Signaling | 33 | 2018 | 119 | 5.850 |
Why?
|
| Sarcoplasmic Reticulum | 38 | 2017 | 164 | 4.600 |
Why?
|
| Calsequestrin | 13 | 2017 | 34 | 3.080 |
Why?
|
| Malignant Hyperthermia | 6 | 2023 | 18 | 3.020 |
Why?
|
| Animals | 92 | 2023 | 3311 | 2.880 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 25 | 2023 | 141 | 2.790 |
Why?
|
| Muscle Contraction | 16 | 2023 | 68 | 2.550 |
Why?
|
| Muscle Fibers, Skeletal | 21 | 2023 | 45 | 2.540 |
Why?
|
| Calcium Channels | 26 | 2019 | 107 | 2.010 |
Why?
|
| Caffeine | 12 | 2023 | 54 | 1.740 |
Why?
|
| Membrane Potentials | 31 | 2013 | 168 | 1.680 |
Why?
|
| Myocardium | 14 | 2017 | 102 | 1.640 |
Why?
|
| Muscles | 15 | 2006 | 56 | 1.580 |
Why?
|
| Myocytes, Cardiac | 8 | 2018 | 86 | 1.540 |
Why?
|
| Ion Channel Gating | 21 | 2017 | 176 | 1.500 |
Why?
|
| Hyperglycemia | 2 | 2023 | 32 | 1.410 |
Why?
|
| Microscopy, Confocal | 17 | 2013 | 81 | 1.380 |
Why?
|
| Rana pipiens | 31 | 2012 | 51 | 1.320 |
Why?
|
| Mice | 22 | 2022 | 1263 | 1.170 |
Why?
|
| Models, Biological | 21 | 2013 | 303 | 1.040 |
Why?
|
| Fluorescent Dyes | 7 | 2013 | 35 | 0.940 |
Why?
|
| Cytosol | 10 | 2012 | 41 | 0.850 |
Why?
|
| Glucose | 2 | 2023 | 45 | 0.830 |
Why?
|
| Halothane | 3 | 2023 | 11 | 0.820 |
Why?
|
| Cell Membrane | 8 | 2011 | 87 | 0.810 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 8 | 0.750 |
Why?
|
| Computer Simulation | 5 | 2019 | 173 | 0.740 |
Why?
|
| In Vitro Techniques | 21 | 2012 | 153 | 0.740 |
Why?
|
| Patch-Clamp Techniques | 20 | 2011 | 97 | 0.720 |
Why?
|
| Homeostasis | 3 | 2012 | 65 | 0.700 |
Why?
|
| Excitation Contraction Coupling | 3 | 2017 | 10 | 0.680 |
Why?
|
| Muscle Fibers, Fast-Twitch | 3 | 2012 | 6 | 0.630 |
Why?
|
| Myocardial Contraction | 4 | 2015 | 37 | 0.630 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 106 | 0.600 |
Why?
|
| Monte Carlo Method | 1 | 2019 | 48 | 0.590 |
Why?
|
| Calcium Channels, L-Type | 5 | 2015 | 52 | 0.580 |
Why?
|
| Microscopy, Fluorescence | 5 | 2022 | 70 | 0.570 |
Why?
|
| Muscular Diseases | 2 | 2015 | 17 | 0.570 |
Why?
|
| Cells, Cultured | 12 | 2018 | 469 | 0.560 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 23 | 0.550 |
Why?
|
| Electrophysiology | 19 | 2008 | 95 | 0.540 |
Why?
|
| Signal Transduction | 7 | 2018 | 398 | 0.530 |
Why?
|
| Disease Susceptibility | 3 | 2023 | 58 | 0.530 |
Why?
|
| Cell Membrane Permeability | 4 | 2011 | 50 | 0.520 |
Why?
|
| Kinetics | 15 | 2013 | 176 | 0.480 |
Why?
|
| Action Potentials | 8 | 2013 | 83 | 0.470 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 25 | 0.450 |
Why?
|
| Biosensing Techniques | 2 | 2011 | 11 | 0.440 |
Why?
|
| Muscle Proteins | 2 | 2015 | 24 | 0.420 |
Why?
|
| Ryanodine | 2 | 2012 | 17 | 0.420 |
Why?
|
| Humans | 21 | 2023 | 22958 | 0.410 |
Why?
|
| Carrier Proteins | 2 | 2015 | 89 | 0.410 |
Why?
|
| Membrane Proteins | 2 | 2023 | 152 | 0.410 |
Why?
|
| Hypothermia | 1 | 2013 | 5 | 0.400 |
Why?
|
| Pyridinium Compounds | 1 | 2013 | 6 | 0.400 |
Why?
|
| Mutation | 4 | 2020 | 330 | 0.360 |
Why?
|
| Rats | 12 | 2016 | 626 | 0.350 |
Why?
|
| Electric Stimulation | 12 | 2004 | 46 | 0.350 |
Why?
|
| Protein Isoforms | 5 | 2022 | 37 | 0.330 |
Why?
|
| Neurons | 1 | 2012 | 273 | 0.330 |
Why?
|
| Rabbits | 10 | 2013 | 165 | 0.300 |
Why?
|
| Phenotype | 3 | 2020 | 261 | 0.290 |
Why?
|
| Central Nervous System Stimulants | 3 | 2000 | 39 | 0.280 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 12 | 0.280 |
Why?
|
| Protein Binding | 3 | 2019 | 115 | 0.280 |
Why?
|
| Algorithms | 7 | 2017 | 304 | 0.270 |
Why?
|
| Magnesium | 6 | 2012 | 36 | 0.260 |
Why?
|
| Mammals | 2 | 2023 | 21 | 0.250 |
Why?
|
| Ion Channels | 4 | 2009 | 204 | 0.240 |
Why?
|
| Sodium Compounds | 3 | 1993 | 4 | 0.230 |
Why?
|
| Perchlorates | 3 | 1993 | 5 | 0.230 |
Why?
|
| Phosphorylation | 4 | 2020 | 132 | 0.230 |
Why?
|
| Image Enhancement | 1 | 2005 | 42 | 0.230 |
Why?
|
| Kidney | 3 | 2003 | 142 | 0.230 |
Why?
|
| Neuromuscular Junction | 3 | 2009 | 7 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2018 | 315 | 0.220 |
Why?
|
| Heart | 3 | 2003 | 59 | 0.210 |
Why?
|
| Calcium Channel Blockers | 3 | 2010 | 30 | 0.210 |
Why?
|
| Heart Ventricles | 4 | 2013 | 82 | 0.210 |
Why?
|
| Mice, Knockout | 4 | 2010 | 282 | 0.200 |
Why?
|
| Adult | 6 | 2020 | 6927 | 0.200 |
Why?
|
| Egtazic Acid | 7 | 2011 | 11 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2007 | 315 | 0.200 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2023 | 11 | 0.200 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 12 | 0.200 |
Why?
|
| Tetracaine | 5 | 2007 | 8 | 0.190 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 33 | 0.190 |
Why?
|
| Anesthetics, Inhalation | 2 | 2020 | 12 | 0.190 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2002 | 4 | 0.180 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2002 | 9 | 0.180 |
Why?
|
| Bone Marrow | 1 | 2002 | 61 | 0.180 |
Why?
|
| Stomach Neoplasms | 1 | 2002 | 32 | 0.180 |
Why?
|
| Anura | 5 | 2004 | 15 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 135 | 0.170 |
Why?
|
| Isoproterenol | 2 | 2013 | 13 | 0.160 |
Why?
|
| Phosphorylase Kinase | 1 | 2020 | 3 | 0.160 |
Why?
|
| Glycogen Phosphorylase, Muscle Form | 1 | 2020 | 3 | 0.160 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2020 | 3 | 0.160 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2013 | 14 | 0.160 |
Why?
|
| Glycogen | 1 | 2020 | 14 | 0.160 |
Why?
|
| Dihydropyridines | 3 | 1998 | 5 | 0.160 |
Why?
|
| Genotype | 1 | 2020 | 248 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2020 | 103 | 0.150 |
Why?
|
| Cytoplasm | 2 | 2013 | 33 | 0.150 |
Why?
|
| Time Factors | 5 | 2005 | 1262 | 0.140 |
Why?
|
| Species Specificity | 4 | 2005 | 34 | 0.140 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 1 | 0.130 |
Why?
|
| Synaptic Transmission | 2 | 1993 | 20 | 0.130 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 1997 | 17 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 138 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2015 | 25 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 526 | 0.120 |
Why?
|
| Barium | 4 | 1998 | 13 | 0.120 |
Why?
|
| Electric Conductivity | 5 | 1997 | 68 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 37 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2009 | 125 | 0.110 |
Why?
|
| Ventricular Function | 2 | 1992 | 8 | 0.110 |
Why?
|
| Male | 4 | 2018 | 12466 | 0.110 |
Why?
|
| Intracellular Membranes | 2 | 1991 | 20 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 262 | 0.100 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2010 | 17 | 0.100 |
Why?
|
| Sodium Channels | 2 | 1992 | 13 | 0.100 |
Why?
|
| Fluorescence | 1 | 2013 | 9 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2011 | 21 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2012 | 40 | 0.100 |
Why?
|
| Binding Sites | 2 | 2009 | 68 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1992 | 7 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 1992 | 47 | 0.090 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 14 | 0.090 |
Why?
|
| Cats | 1 | 2012 | 28 | 0.090 |
Why?
|
| Biophysical Phenomena | 2 | 2002 | 26 | 0.090 |
Why?
|
| Biophysics | 2 | 2002 | 32 | 0.090 |
Why?
|
| Nitrendipine | 1 | 1991 | 2 | 0.090 |
Why?
|
| Cell Line | 3 | 2003 | 250 | 0.090 |
Why?
|
| Mitochondria, Muscle | 1 | 2011 | 4 | 0.090 |
Why?
|
| Muscle Cells | 1 | 2011 | 12 | 0.090 |
Why?
|
| Sensory Receptor Cells | 1 | 1991 | 9 | 0.090 |
Why?
|
| Ligands | 1 | 2011 | 37 | 0.090 |
Why?
|
| Saponins | 2 | 2006 | 2 | 0.090 |
Why?
|
| Female | 4 | 2020 | 12958 | 0.090 |
Why?
|
| Second Messenger Systems | 1 | 1991 | 6 | 0.090 |
Why?
|
| Xanthenes | 3 | 2000 | 4 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 153 | 0.090 |
Why?
|
| Aniline Compounds | 3 | 2000 | 29 | 0.090 |
Why?
|
| Aged | 2 | 2020 | 7448 | 0.080 |
Why?
|
| Middle Aged | 2 | 2020 | 7911 | 0.080 |
Why?
|
| Buffers | 1 | 2010 | 9 | 0.080 |
Why?
|
| Anesthetics, Local | 2 | 2003 | 71 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2009 | 5 | 0.080 |
Why?
|
| Gene Expression | 1 | 2010 | 178 | 0.080 |
Why?
|
| Feedback | 3 | 1997 | 33 | 0.080 |
Why?
|
| Metals, Alkali | 1 | 1989 | 1 | 0.080 |
Why?
|
| Metals, Alkaline Earth | 1 | 1989 | 1 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2009 | 25 | 0.080 |
Why?
|
| Mitochondria | 1 | 2009 | 55 | 0.080 |
Why?
|
| Guinea Pigs | 3 | 1993 | 23 | 0.080 |
Why?
|
| Neutrophils | 1 | 2009 | 91 | 0.070 |
Why?
|
| Basophils | 1 | 2008 | 7 | 0.070 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 9 | 0.070 |
Why?
|
| Proton Pumps | 1 | 2008 | 12 | 0.070 |
Why?
|
| Chelating Agents | 2 | 2011 | 13 | 0.070 |
Why?
|
| Lipid Bilayers | 4 | 2003 | 48 | 0.070 |
Why?
|
| Diffusion | 1 | 2008 | 24 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2008 | 38 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 89 | 0.070 |
Why?
|
| Ranidae | 3 | 1991 | 3 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2007 | 7 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 15 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 35 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 439 | 0.060 |
Why?
|
| Biological Transport | 2 | 1999 | 38 | 0.060 |
Why?
|
| Markov Chains | 2 | 2002 | 30 | 0.060 |
Why?
|
| Thermodynamics | 2 | 2002 | 42 | 0.060 |
Why?
|
| Sulfates | 1 | 2005 | 3 | 0.060 |
Why?
|
| Solutions | 1 | 2005 | 15 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2005 | 21 | 0.060 |
Why?
|
| Organelles | 1 | 2005 | 4 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 32 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 59 | 0.060 |
Why?
|
| Naphthalenesulfonates | 1 | 2004 | 1 | 0.060 |
Why?
|
| Phenolsulfonphthalein | 1 | 2004 | 1 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2004 | 14 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2003 | 14 | 0.050 |
Why?
|
| Electromagnetic Fields | 1 | 2003 | 9 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 42 | 0.050 |
Why?
|
| Rana catesbeiana | 2 | 2003 | 9 | 0.050 |
Why?
|
| Extracellular Space | 2 | 1996 | 10 | 0.050 |
Why?
|
| Oscillometry | 1 | 2002 | 5 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2002 | 113 | 0.050 |
Why?
|
| Probability | 2 | 1992 | 71 | 0.050 |
Why?
|
| Necrosis | 1 | 2002 | 24 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2002 | 50 | 0.050 |
Why?
|
| Fever | 1 | 2002 | 32 | 0.040 |
Why?
|
| Gallopamil | 2 | 1992 | 8 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2000 | 17 | 0.040 |
Why?
|
| Biomarkers | 2 | 2017 | 476 | 0.040 |
Why?
|
| Muscle Development | 1 | 1999 | 3 | 0.040 |
Why?
|
| Artifacts | 1 | 1999 | 29 | 0.040 |
Why?
|
| Benzopyrans | 2 | 2009 | 7 | 0.040 |
Why?
|
| Pain | 1 | 2002 | 332 | 0.040 |
Why?
|
| Xenopus | 1 | 1998 | 4 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1998 | 24 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 27 | 0.040 |
Why?
|
| Diastole | 2 | 2010 | 28 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 35 | 0.040 |
Why?
|
| Base Sequence | 1 | 1998 | 101 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 592 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 147 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 112 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 185 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 1998 | 284 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 95 | 0.030 |
Why?
|
| Platelet Count | 1 | 2017 | 10 | 0.030 |
Why?
|
| Spain | 1 | 2017 | 8 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2017 | 15 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2016 | 1 | 0.030 |
Why?
|
| Mannose | 1 | 2016 | 2 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2017 | 74 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 111 | 0.030 |
Why?
|
| Sodium | 2 | 1997 | 56 | 0.030 |
Why?
|
| Perfusion | 1 | 1996 | 17 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 100 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 95 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 173 | 0.030 |
Why?
|
| Rana esculenta | 1 | 1996 | 2 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 11 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 20 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 426 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 20 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 60 | 0.030 |
Why?
|
| Membranes | 1 | 1995 | 9 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 483 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 567 | 0.030 |
Why?
|
| Ion Transport | 1 | 1994 | 28 | 0.030 |
Why?
|
| Chlorides | 1 | 1994 | 25 | 0.030 |
Why?
|
| Cadmium | 1 | 1993 | 11 | 0.030 |
Why?
|
| Isradipine | 1 | 1993 | 2 | 0.030 |
Why?
|
| Calcium Radioisotopes | 1 | 1993 | 2 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 1993 | 3 | 0.030 |
Why?
|
| Edetic Acid | 1 | 1993 | 3 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1993 | 8 | 0.030 |
Why?
|
| Cations | 1 | 1993 | 15 | 0.030 |
Why?
|
| Child | 1 | 2017 | 1157 | 0.030 |
Why?
|
| Transfection | 2 | 2007 | 117 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 6 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1992 | 11 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 1651 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 1881 | 0.020 |
Why?
|
| Mathematics | 1 | 1991 | 27 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 20 | 0.020 |
Why?
|
| Ruthenium Red | 1 | 1991 | 7 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 1991 | 5 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 1991 | 24 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 2 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 30 | 0.020 |
Why?
|
| Ruthenium Compounds | 1 | 2009 | 2 | 0.020 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2009 | 2 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 4 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2009 | 13 | 0.020 |
Why?
|
| Naphthols | 1 | 2009 | 3 | 0.020 |
Why?
|
| Rhodamines | 1 | 2009 | 4 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2009 | 6 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 1989 | 3 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 2941 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2009 | 44 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 1991 | 536 | 0.020 |
Why?
|
| Protons | 1 | 2009 | 84 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2008 | 4 | 0.020 |
Why?
|
| Histamine | 1 | 2008 | 7 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2008 | 12 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2008 | 11 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 30 | 0.020 |
Why?
|
| Zinc | 1 | 2008 | 39 | 0.020 |
Why?
|
| Colforsin | 1 | 2007 | 12 | 0.020 |
Why?
|
| Calmodulin | 1 | 2007 | 7 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2007 | 12 | 0.020 |
Why?
|
| Benzylamines | 1 | 2007 | 12 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2007 | 45 | 0.020 |
Why?
|
| Peptides | 1 | 2007 | 89 | 0.020 |
Why?
|
| Heart Failure | 1 | 2007 | 141 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 68 | 0.010 |
Why?
|
| Potassium | 1 | 2003 | 59 | 0.010 |
Why?
|
| Calibration | 1 | 2002 | 16 | 0.010 |
Why?
|
| Biotransformation | 1 | 1997 | 5 | 0.010 |
Why?
|
| Myofibrils | 1 | 1988 | 6 | 0.000 |
Why?
|